Document Detail

Effects of knowledge, education, and experience on acceptance of first trimester screening for chromosomal anomalies.
MedLine Citation:
PMID:  20235896     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To assess pregnant women's knowledge and understanding of first trimester prenatal screening (nuchal translucency, maternal serum free beta-human chorionic gonadotrophin and pregnancy-associated plasma-protein-A), to evaluate the impact of a new information booklet and investigate the effects of education and experiential knowledge of congenital disabilities on the perceived likelihood of accepting prenatal screening. DESIGN: A quasi-experimental quantitative study with a self-completion questionnaire. SETTING: Five different maternity care clinics in Iceland. POPULATION: Expectant mothers in first trimester of pregnancy (n = 379). MATERIAL AND METHODS: Expectant mothers were divided into two groups, an intervention and a control group, both receiving traditional care and information. The intervention group additionally received an information booklet about prenatal screening and diagnosis. MAIN OUTCOME MEASURES: Women's knowledge score of prenatal screening. The correlation between education, knowledge score, experiential knowledge of congenital disabilities, and the likelihood of accepting prenatal screening. RESULTS: More than half of the women (57%) believed they received sufficient information to make an informed decision about screening. Knowledge scores were significantly higher for the intervention group (with mean 4.8 compared with 3.7 on a 0-8 scale, p < 0.0001). Those with higher scores were more likely to accept screening (p < 0.0001). Women with experiential knowledge of congenital anomalies in their own families were more likely to accept prenatal screening (p = 0.017). CONCLUSIONS: Various factors, e.g. experiential knowledge, education and information about prenatal screening affect the likelihood of participation in prenatal screening programs. More information results in better knowledge and higher uptake rate.
Vigdis Stefansdottir; Heather Skirton; Kristjan Jonasson; Hildur Hardardottir; Jon Johannes Jonsson
Related Documents :
21098846 - Model-predicted performance of second-trimester down syndrome screening with sonographi...
9572446 - Second trimester maternal dimeric inhibin-a in the multiple-marker screening test for d...
20832736 - Screening for hyperglycaemia in pregnancy: consensus and controversy.
7514056 - Maternal serum markers. estimation of the risk of down's syndrome: a prospective study.
8841226 - Fetal startle response observed under ultrasonography: a good predictor of a reassuring...
8408456 - Amelioration of some pregnancy-associated variations in thyroid function by iodine supp...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta obstetricia et gynecologica Scandinavica     Volume:  89     ISSN:  1600-0412     ISO Abbreviation:  Acta Obstet Gynecol Scand     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-29     Completed Date:  2010-07-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370343     Medline TA:  Acta Obstet Gynecol Scand     Country:  England    
Other Details:
Languages:  eng     Pagination:  931-8     Citation Subset:  IM    
Department of Genetics and Molecular Medicine, Landspitali University Hospital, Iceland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chorionic Gonadotropin, beta Subunit, Human / blood
Chromosome Disorders / diagnosis*
Genetic Testing / utilization*
Health Knowledge, Attitudes, Practice*
Intervention Studies
Maternal Health Services / statistics & numerical data,  utilization
Nuchal Translucency Measurement / methods
Patient Acceptance of Health Care / statistics & numerical data*
Patient Compliance
Patient Education as Topic
Pregnancy Trimester, First
Pregnancy-Associated Plasma Protein-A / metabolism
Prenatal Care / utilization
Prenatal Diagnosis / methods*,  trends
Risk Factors
Reg. No./Substance:
0/Chorionic Gonadotropin, beta Subunit, Human; EC 3.4.24.-/Pregnancy-Associated Plasma Protein-A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prenatal tobacco prevention and cessation interventions for women in low- and middle-income countrie...
Next Document:  Macrosomia: mode of delivery and pregnancy outcome.